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Abstract
Intraoperative Pain Management: Attenuating Postoperative Pain in Pediatric Patients
More than 5 million children undergo surgery in the United States each year, and it is 
estimated that up to 75% (3.75 million) of them experience significant postoperative pain 
(Fortier, MacLaren, Martink, Perret-Karimi, & Kain, 2009). While we have come a long way in 
our knowledge of pain in children, it is often found that pain is inadequately assessed and treated. 
Aside from the cost associated with increased utilization of medical visits, psychological 
implications (anxiety, avoidance, sleep disturbances), and increased parental distress related to 
pediatric pain, there are many physiologic changes associated with pain that may delay or 
prevent wound healing. Increasing awareness of pharmacologic trends in pediatric analgesia may 
assist anesthesia staff in providing adequate intraoperative analgesia and decreasing 
postoperative pain.
Many components that contribute to postoperative pediatric pain have been studied. Due 
to the extensive amount of research available on this topic, for the purposes of this independent 
project, research will be limited to those children ages 2-12 years old undergoing tonsillectomy 
and adenoidectomy (T&A). T&A is one of the most common pediatric surgical procedures and is 
well known to be associated with significant postoperative pain (Fortier et all., 2009).
The purpose of this independent project is to identify pharmacologic agents that are 
presently being employed intraoperatively to provide analgesia to the pediatric population. A 
comprehensive review of the literature was performed using PubMed and CINAHL databases. 
Current research findings on the topic of interest and related topics were reviewed. Melzack and 
Wall’s gate control theory of pain was used as a theoretical framework.
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Intraoperative Pain Management: Attenuating Postoperative Pain in Pediatric Patients
Pain is defined by the International Association for the Study of Pain as “an unpleasant 
sensory and emotional experience associated with actual or potential tissue damage, or described 
in terms of such damage” (IASP, 1994). Certified Registered Nurse Anesthetists (CRNAs) and 
other anesthesia providers are responsible for providing anesthesia, amnesia, and analgesia to 
patients who are undergoing surgical procedures. Analgesia is defined as the absence of pain in 
response to stimulation which would normally be painful (IASP, 1994). The physiological 
indicators of blood pressure, heart rate, and respiratory rate are among the most commonly used 
to assess pain in patients who are anesthetized. Inability to communicate verbally does not 
negate the possibility that an individual is experiencing pain and is in need of appropriate pain- 
relieving treatment (IASP, 1994).
Good pain management is associated with improved outcomes from surgery, quicker 
clinical recovery, shorter hospital stays, fewer readmissions, improved quality of life, and 
improved patient and parent satisfaction (Trudeau, Lamb, Gowans, & Lauder, 2009). In light of 
the present advances in technology and the progress that has been made in the science of 
pharmacology, a specific formula for providing children the most effective analgesia has eluded 
healthcare providers due to variability in children’s perception and response to pain. Research 
conducted on the pediatric population is also subject to many ethical considerations which results 
in comparably few randomized controlled trials that direct pain management in children. 
Anesthesia providers must strive to provide adequate analgesia to the pediatric population. The 
clinical question of interest remains: what pharmacologic agents utilized intraoperatively provide 
the most effective analgesia in the immediate postoperative period?
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Purpose
The purpose of this independent project is to provide a current review of literature on 
intraoperative analgesic agents used to treat pain in the pediatric (2-12 years) population 
undergoing T&A. In order to adequately provide effective treatment based on research, clinicians 
need to be kept informed on the latest results in pediatric and pharmacologic studies. This 
information will be presented at the North Dakota Association of Nurse Anesthetists bi-annual 
meeting in Bismarck, North Dakota. With current evidence for practice presented, providers may 
incorporate the results of this review into their individual practices to provide more effective 
intraoperative analgesic management.
The basis of this project is to alert current practitioners to the significance of this 
problem, provide a review of the pain pathway, review the historical perspective of pain in 
pediatric patients, and to provide a review of literature on the current pharmacologic treatments 
of intraoperative pain.
Significance
Up to 75% of children undergoing surgery experience postoperative pain with up to 50% 
experiencing severe pain (defined as a pain score greater than or equal to 8) after surgery (Fortier 
et al., 2010; Bean-Lijewski, Kruitbosch, Hutchinson & Browne, 2007). According to the 
National Health Statistics Reports (Hing & Burt, 2007), ambulatory (outpatient) surgery has been 
increasing in the United States and T&A is among the most common procedures performed on 
an outpatient basis for children under 15 years of age. This particular surgery is associated with 
increased risk of pain after surgery, adverse respiratory events, bleeding, and postoperative 
nausea and vomiting (Gulhas et al., 2003). It is important for anesthesia providers to adequately
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treat intraoperative pain in order to smooth the transition from the operating suite to the PACU. 
Readiness for discharge home from the PACU is confirmed by patients scoring > 9 on the 
standardized postanesthesia discharge scoring system (PADS) (Marschall & Chung, 1999). The 
criterion in which the system is based includes vital signs, activity level, nausea and vomiting, 
pain, and bleeding. This scoring system highlights the importance of choosing the appropriate 
pharmacologic agents to be administered intraoperatively. Pain at an unacceptable level to the 
patient or that which cannot be controlled with oral medication may delay discharge from the 
PACU and thus increase the cost of patient care.
Painful stimuli produce a “fight-or-flighf ’ release of stress hormones which may 
exacerbate injury, prevent wound healing, lead to infection, and prolong hospitalization. Failure 
to control pain after T&A leads to decreased oral intake of liquids, dehydration, and greater risk 
of hemorrhage from healing surgical wounds (Mohommad, Shahrbano, & Ulhaq, 2008).
Adequate treatment of perioperative pain in children can reduce the morbidity and mortality 
associated with surgery caused by activation of the stress response.
Kain et al. (2006) performed a cohort study on children undergoing tonsillectomy and 
adenoidectomy. Parental assessment of their child’s pain was scored, the children’s self report of 
pain was rated, and analgesic consumption was recorded throughout the postoperative recovery 
period (defined as the time the patient entered the post-anesthesia recovery until 14 days 
following the procedure.) Though it is difficult to determine whether conclusions are the result of 
association or cause-and-effect, increased anxiety before surgery was associated with increased 
postoperative pain, analgesic consumption, sleeping problems and decreased postoperative 
eating. Lonnqvist & Morton (2006) suggest careful pre-operative preparation of children and 
their families in order to minimize fear and anxiety.
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Theoretical Framework
The gate control theory of pain, proposed by Melzack and Wall in 1965, was chosen as 
the theoretical framework and used to analyze the relationship between pharmacologic 
intervention and perception of pain. Certified Registered Nurse Anesthetists (CRNAs) are 
responsible for both altering the way in which patients perceive pain and providing effective 
analgesia to optimize conditions for recovery from a surgical procedure that was indeed painful. 
In order to utilize Melzack and Wall’s theory and provide analgesia, a basic understanding of the 
pain pathway is needed.
Pain signal processing involves transduction, transmission, modulation, & perception. 
Transduction is the process by which afferent nerve endings in the peripheral tissues participate 
in translating noxious stimuli into nociceptive impulses (painedu.org). Various stimuli may 
facilitate the transduction of pain. These include mechanical stimulation from a sharp object, 
potassium released from the inside of damaged cells, prostaglandins, histamines and bradykinin 
from immune cells that invade an area during inflammation, and substance P released from 
nearby nerve fibers. These stimuli cause the propagation of action potentials in the nociceptor 
neurons leading to the transduction of pain.
Transmission is the process by which impulses are sent to the dorsal horn of the spinal 
cord, and then along the sensory tracts to the brain (painedu.org). Primary afferent neurons are 
located in the dorsal root ganglia, which lie in the vertebral foramina at each spinal cord level 
(Morgan, Mikhail, & Murray, 2006). Each neuron has a single axon that bifurcates, sending one 
end to the peripheral tissues it innervates and the other into the dorsal horn of the spinal cord 
(Morgan, Mikhail, & Murray, 2006). In the dorsal horn, the primary afferent neuron synapses 
with a second-order neuron whose axons cross the midline and ascend in the contralateral
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spinothalamic tract to reach the thalamus, reticular formation, nucleus raphe magnus, and 
periaqueductal gray (Morgan, Mikhail, & Murray, 2006). Second-order neurons synapse in 
thalamic nuclei with third-order neurons, which in turn send projections through the internal 
capsule and corona radiata to the postcentral gyrus of the cerebral cortex where sensations of 
pain, temperature, touch and pressure are interpreted and responses to the sensations are initiated 
(Nagelhout & Plaus, 2010).
Modulation is the process of dampening or amplifying the pain-related neural signals 
(painedu.org). This is the step anesthesia providers may alter with pharmacologic agents. 
Modulation may occur peripherally at the nociceptor, in the spinal cord, or in supraspinal 
structures (Morgan, Mikhail, & Murray, 2006). Rich arrays of opioid receptors (mu, kappa, and 
delta) are present in the dorsal horn (painedu.com). In addition to an ascending tract, the 
nociceptive system contains descending pathways that send neurons from the frontal cortex, 
hypothalamus and other areas of the brain to the midbrain and medulla, and also down to the 
spinal cord (painedu.com). The result of the descending inhibitory input is that incoming 
nociceptive signals from the periphery are dampened, or even blocked entirely, at the “gate” in 
the dorsal horn (painedu.com).
Perception is the conscious awareness of the experience of pain. Perception results from 
the interaction of transduction, transmission, modulation, psychological aspects and other 
characteristics of the individual. All four steps along the pain pathway are tied together by the 
Gate Control Theory (painedu.com).
Melzack and Wall’s gate control theory of pain proposes that the dorsal horn of the spinal 
cord operates similar to a gate by modulating the flow of nerve impulses from the peripheral 
fibers to the central nervous system. The intemuncial neurons involved in the gating mechanism
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are activated by large-diameter, faster-propagating fibers that carry tactile information (Porth, 
2005). The transmission of impulses from the small-diameter myelinated and unmyelinated pain 
fibers could be blocked if fired simultaneously with the large-diameter fibers (Porth, 2005). The 
“gate” is influenced by the integration of inputs from sensory neurons, the segmental spinal cord 
level, and multiple descending influences from the brain. These inputs determine whether the 
gate will be opened or closed, either increasing or decreasing the intensity of the ascending pain 
signal (painedu.com). Melzack and Wall (1965) believed that past experiences, culture, attention 
and activities of the nervous system taking place simultaneously with the inj ury all determined 
how the pain would be perceived. The gate, then, can be opened or closed by transduction, 
transmission and modulation, and psychological intervention. It may also be influenced by 
pharmacologic manipulation that is administered by anesthesia providers.
Definitions
For the purpose of this study, the following definitions are provided:
Intraoperative -  Relating to the period of time during a surgical procedure
Postoperative -  Relating to the period of time following a surgical operation until discharge from 
the hospital or surgical center
Perioperative -  The period of time extending from when a patient goes into the hospital for 
surgery until the patient is discharged home. Before, during and after a surgery
General Anesthesia -  Using anesthetic drugs to induce a reversible state of consciousness in 
which an individual is unable to respond to painful stimuli
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Pain -  “An unpleasant sensory and emotional experience associated with actual or potential 
tissue damage, or described in terms of such damage” as defined by the International Association 
for the Study of Pain. Pain is subjective and response to pain may be highly variable among 
persons and may be highly variable in the same person at different times.
Analgesia - The absence of pain in response to stimulation which would normally be painful 
(IASP, 1994).
Noxious Stimuli -  Another name for pain
Nociceptors - Specialized receptors that transduce noxious stimuli. Noci is Latin for harm
Nociception - The process by which a painful stimulus is relayed from the site of stimulation to 
the central nervous system. Nociceptive pain is pain caused by activation or sensitization of 
peripheral nociceptors. All nociception produces pain, but not all pain results from nociception. 
Serves to detect, localize, and limit tissue damage. Postoperative pain falls into this category.
Acute pain - Pain that is caused by noxious stimulation due to injury, a disease process, or the 
abnormal function of muscle or viscera. It is nearly always nociceptive. Moderate to severe acute 
pain may adversely influence postoperative morbidity and mortality.
Ambulatory surgery -  A surgery in which a patient undergoes a procedure and is discharged 
home on the same day. Outpatient surgery
Postanesthesia Care Unit (PACU) - The area in which patients first recover from anesthesia.
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Process
A comprehensive review of the literature was performed using CINAHL and PubMed 
databases. Search terms utilized included but were not limited to pediatric, anesthesia, analgesia, 
intraoperative, pain, tonsillectomy and adenoidectomy, opioids, acetaminophen, morphine, 
fentanyl, total intravenous anesthesia, nonsteroidal anti-inflammatory, and hydromorphone. 
MESH terms utilized included but were not limited to pediatric, analgesia, tonsillectomy and 
adenoidectomy, intraoperative and postoperative. The material discovered in the literature review 
had a time range between the years 1941 and 2011. The basis of the review of literature was to 
gain a broader perspective on the medications that are currently being used and studied in the 
treatment of intraoperative pediatric pain. Types of studies found with related material included 
prospective comparisons, meta-analysis, and randomized double blind studies.
The delivery of this information will be provided to CRNAs and other anesthesia 
providers in the clinical setting, as well as at the North Dakota Association of Nurse Anesthetists 
bi-annual meeting. Information will be provided in the form of a power point lecture with the 
opportunity for discussion and questions after the material is presented.
Review of Literature
Historically, there have been myths about the ability of infants and children to recognize 
and/or remember pain. A study by McGraw (1941) conveyed a message to many clinicians that 
infants do not feel pain or have any memory of pain therefore they do not require analgesia.
There were also reports that children up to the age of two years old did not have the neurological 
capability of experiencing or remembering pain (Pabis, Kowalczyk, & Kulik, 2011). This 
“evidence” combined with the fear of opioid effects in children provided the basis for lack of
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analgesic treatment in children for more than 30 years. In the 1950s, Italy first began researching 
pain in children. Before the 1970’s, pediatric pain literature was almost non-existent. A search on 
pediatric pain via the University of North Dakota’s Harley E. French Library of the Health 
Sciences revealed only nine articles published on pediatric surgical pain before 1980.
Throughout the 1980s, there were 58 articles and discussion of pain management in the newborn. 
The majority of information on pain in children started in the 1990s and continues today. In 
2001, the Joint Commission for the Accreditation of Healthcare Organizations (JCAHO) 
disseminated standards for pediatric pain. More knowledge is being gained on pediatric pain; 
however, there are many ethical considerations when performing studies on children, especially 
when researching pharmacologic methods of treatment.
It is important to review the past to realize how far research has come in the area of pain 
management in children. Lowery, Hardman, Manning, Hall, & Anand (2007) describe the 
development of structures needed to experience pain using postconceptual age. Sensory fibers 
are abundant by 20 weeks; a functional spinal reflex is present by 19 weeks; connections to the 
thalamus are present by 20 weeks; and connections to subplate neurons are present by 17 weeks 
with intensive differentiation by 25 weeks (Lowery et al., 2007). According to Lowery et al. 
(2007), the ability for a fetus to experience pain occurs when mature thalamocortical projections 
are present at 29-30 weeks. Research conducted during the past few decades has provided 
valuable data to refute previously held misconceptions concerning the inability for children to 
experience pain. This has considerably changed the practice of health care providers.
Many factors play a role in the pediatric patient’s perception of pain and there are just as 
many studies available on attenuating postoperative pain. Treatments are being employed at 
various times throughout a child’s perioperative experience and may include nonpharmacologic
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methods such as: music therapy, pet therapy, hypnosis, play therapy, modeling and rehearsal 
which are used to help decrease anxiety preoperatively and postoperatively. Reduced anxiety 
may also come from allowing parents to be present during induction of anesthesia or from 
pharmacological agents provided orally.
The primary focus of this literature review involves the use of pharmacologic techniques 
employed intraoperatively to decrease pediatric pain in the immediate postoperative period. The 
medications reviewed will be divided into either non-opioid medications or opioid medications.
Non-Opioid Medications
Nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit platelet cyclooxygenase which is 
an enzyme that catalyzes the synthesis of prostaglandins from arachidonic acid (Stoelting & 
Hillier, 2006). Prostaglandins mediate a number of bodily processes including inflammation and 
pain. NSAIDS also prolong bleeding time by preventing the biosynthesis of thromboxane A2, 
leading to reduced platelet aggregation (Stoelting & Hillier, 2006). NSAIDs are frequently used 
in children for treatment of fever (antipyretic), postoperative pain (analgesic) and inflammatory 
disorders (anti-inflammatory). They can be administered orally, intravascularly or 
intramuscularly. According to Rainsford (2009), the volume of distribution (Vd) and plasma 
clearance (CL) of NSAIDs are increased in children (up to 5 years old) compared to adults, 
though elimination half-life is similar in children and adults. These pharmacokinetic differences 
may be clinically significant and children may require relatively higher loading and/or 
maintenance doses. As children age, lower dosages may be required to achieve the same level of 
pain relief. According to Kokki (2003), NSAIDs are more effective in preventing pain than in the 
relief of established pain. NSAIDs are contraindicated in patients in whom sensitivity reactions 
are precipitated by aspirin (acetylsalicylic acid) or other NSAIDs. They should be used with
INTRAOPERATIVE PAIN MANAGEMENT 14
caution in children with liver dysfunction, impaired renal function, hypovolemia or hypotension, 
coagulation disorders, thrombocytopenia, or active bleeding from any cause (Kokki, 2003).
NS AIDS are generally well tolerated and severe adverse effects in children are rare. The 
analgesic efficacy of ketorolac, ketoprofen, diclofenac and ibuprofen in the treatment of 
postoperative pain has been mainly studied following a single dose, in children of > or = 1 year 
of age undergoing minor surgeries (Litalien & Jacqz-Aigrain, 2001). A few studies indicate that 
ketorolac may increase bleeding more so than other NSAIDs, but evidence is conflicting (Kokki, 
2003).
Ketorolac is a NS AID with potent analgesic effects and relatively low risk of adverse 
effects (Forrest, Heitlinger, & Revell, 1997). It is a particularly useful drug for postoperative pain 
management both as the sole analgesic and to supplement opioids. Ketorolac reversibly inhibits 
the metabolism of arachidonic acid, which is released when cells are damaged (Stoelting & 
Hillier, 2006). According to Bean-Lijewski & Hunt (1996), metabolism of arachidonic acid via 
the cyclooxygenase pathway results in the production of prostaglandins and thromboxanes, 
which are potent vasodilators and modulators of peripheral pain. The result is a decreased 
sensitization of tissue nociceptors that occurs with surgery. Ketorolac when combined with an 
opioid exhibits marked opioid-sparing effects, allowing a lower dosage of opioid to be used and 
improves the degree and quality of pain relief. Using the drugs together reduces the incidence of 
opioid-related adverse effects such as respiratory depression, cardiovascular depression, 
nausea/vomiting, urinary retention, sedation and ileus.
Of the studies reviewed, the recommended intravenous dosage of ketorolac in children is 
0.5-0.75 mg/kg. The maximum duration of treatment for ketorolac is 48 (1 mg/kg)-72 (0.5 
mg/kg) hours. Ketorolac is approved in pediatric patients >2 years. It may induce life-
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threatening bronchospasm in patients with nasal polyposis, asthma, and aspirin sensitivity 
(Stoelting & Hillier, 2006).
Numerous clinical trials of postoperative pain treatment in children have shown that 
ketorolac is as effective as the major opioid analgesics and more effective than codeine (Forrest 
et ah, 1997). While ketorolac has been proven to improve post-tonsillectomy pain in children, 
controversy exists regarding use of ketorolac and the risk of postoperative hemorrhage in 
children undergoing this procedure. Marret, Flahault, Samama, & Bonnet (2003) conducted a 
small meta-analysis of seven prospective, randomized, double-blind trials in adults and children. 
Results indicated that the risk of reoperation for hemostasis, which is associated with a high risk 
of morbidity related to pulmonary aspiration and difficult tracheal intubation , was nearly 
fourfold greater after NSAIDs, prompting recommendations to avoid NSAIDs following ENT 
surgery (Marret et ah, 2003). A study designed by Splinter, Rhine, Roberts, Reid, & MacNeill 
(1996) was meant to test the effect of codeine and ketorolac on postoperative vomiting in 
tonsillectomy patients. The study was terminated due to ethical reasons after five of the 35 
patients who received ketorolac required admission to the hospital due to bleeding.
Evidence of contradictory studies includes one performed by Agrawal, Gerson, Seligman, 
Dsida in 1999. Over a 2-year period investigators examined office records of 310 pediatric 
patients, 213 who received ketorolac administered as a single dose at the conclusion of the 
tonsillectomy procedure and 97 patients who did not receive ketorolac. Postoperative 
hemorrhage was not found to differ significantly between these 2 groups (2.3% vs. 3.1% 
respectively, P=0.71). Ketorolac was not found to increase the incidence of posttonsillectomy 
hemorrhage and was actually associated with a significant decrease in the length of hospital stay 
as well as a decreased likelihood of overnight hospital stay after surgery.
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A more recent evaluation by the Cochrane Anesthesia Review Group included 13 
pediatric trials involving 955 children undergoing tonsillectomy and receiving NSAIDs 
perioperatively compared to another analgesic or placebo. In the review, a subgroup analysis for 
ketorolac was performed. NSAIDs were not found to significantly alter perioperative bleeding 
(Peto odds ratio 1.46, 95% Cl 0.49-4.40) and in seven trials involving 567 children the odds ratio 
for bleeding requiring reoperation was 0.91 (Cl 0.22-3.71) when ketorolac was excluded 
(Cardwell, Siviter, & Smith, 2005).
Many uncontrollable elements influence whether patients will experience 
posttonsillectomy hemorrhage, such as the skill of the surgeon, operative technique used, and the 
patient’s coagulation status which is not routinely performed. While NSAIDs have been proven 
to decrease postoperative pain, ketorolac use in tonsillectomy patients remains controversial due 
to the potential increase in postoperative bleeding.
Perioperative use of cyclooxygenase (COX)-2 selective NSAIDs may offer a safer 
alternative in the management of posttonsillectomy pain than nonselective NSAIDs currently 
available in pediatric formulations. According to Ivani, Tonetti, & Mossetti (2005), COX-2 
inhibitors do not interfere with platelet function and are associated with fewer bleeding 
complications. The most recent studies on COX-2 selective NSAIDS suggest analgesic effects 
similar to conventional NSAIDS when used for acute pain postoperatively or preoperatively.
Acetaminophen in a widely used analgesic and antipyretic, however it lacks significant 
anti-inflammatory effects and the mode of action is not completely understood. Its site of 
analgesic action is within the CNS and it may also work to activate serotonin receptors inhibiting 
the cyclooxygenase pathway in prostaglandin synthesis (Stoelting & Hillier, 2006). In the past, 
acetaminophen had been given to children primarily by rectal suppository after induction of
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anesthesia. Studies have determined that an initial rectal acetaminophen dose of approximately 
40 mg/kg is needed in children to achieve target antipyretic serum concentrations. It is now 
available on the market as Ofirmev, a drug that may be administered intravenously (IV). IV 
infusion dosing for children 2-12 years old is 10-15 mg/kg every 4- 6 hours, not to exceed five 
doses (50-75 mg/kg) in 24 hours. When given IV it must be administered over 15 minutes and 
the maximum dose per day is 75 mg/kg. Ofirmev does not bind significantly to serum proteins. 
Maximum concentration occurs at the end of the 15 minute intravenous infusion of ofirmev, 
which is 70% higher than following oral administration of acetaminophen. Unlike salicylates, 
acetaminophen does not produce gastric irritation or alter aggregation characteristics of platelets. 
Bleeding time is not prolonged as it is with NSAIDs resulting in lower risk with use in patients 
undergoing tonsillectomy. The risk associated with acetaminophen use includes hepatic toxicity 
with daily dosages that exceed 75 mg/kg and it is contraindicated in patients with 
hypersensitivity to acetaminophen or in patients with severe hepatic impairment or active liver 
disease. Acetaminophen is a safe and effective analgesic, however often provides unsatisfactory 
analgesia when used alone (Romsing, Ostergaard, Drozdziewicz, Schultz, & Ravn, 2000).
Acetaminophen has been used for analgesia for years; however, Ofirmev (the intravenous 
form of acetaminophen) was just recently launched in the United States on the 18th of January, 
2011. The effectiveness and analgesic duration of IV versus rectal acetaminophen can be found 
in a trial completed by Capici, et al, (2008). The randomized, controlled study involved 50 
children undergoing adenoidectomy/tonsillectomy assigned to either receive 40 mg/kg rectal or 
15 mg/kg IV acetaminophen. The time to first rescue analgesia request was longer in children 
receiving rectal acetaminophen (median 10 hrs) compared to those receiving IV acetaminophen 
(median 7 hrs), indicating rectal acetaminophen 40 mg/kg provides longer analgesia for
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moderately painful procedures when compared to 15 mg/kg acetaminophen IV. Research on IV 
acetaminophen in children is limited due to its recent release; however Atef & Fawaz (2008) 
conducted a randomized, double blind, prospective, placebo-controlled study on 76 adult 
subjects. Subjects were either assigned to an acetaminophen group or the placebo group to 
determine the analgesic efficacy and safety of intravenous acetaminophen in adults undergoing 
bipolar diathermy tonsillectomy. Results indicated subjects in the acetaminophen group required 
significantly less rescue analgesics than those in the placebo group (P < 0.001). A disadvantage 
of using IV acetaminophen is the time frame of administration. Indications include giving the 
infusion over a period of 15 minutes before the start of surgery. General anesthesia in pediatric 
patients is typically induced using inhalation agents, which is immediately followed by obtaining 
IV access. Administering the medication prior to surgery would require IV access to be 
established preoperatively or may require waiting for 15 minutes before proceeding with the 
surgery. This puts the patient at risk of being under general anesthesia for a longer period of 
time. More information will continue to emerge on this new form of acetaminophen.
Dexamethasone is a synthetic corticosteroid with an anti-inflammatory effect of 0.75 mg 
equivalent to that of 20 mg of cortisol (Stoelting & Hillier, 2006). Dexamethasone has combined 
antiemetic and anti-inflammatory effects that may decrease postoperative tissue injury, edema 
and pain after electrocautery tonsillectomy (Elhakim, Ali, Rashed, Riad, & Refat, 2003). 
Dexamethasone is being widely used in the pediatric population for tonsillectomy. It has been 
shown to attenuate the morbidity that children experience in the first 2 days after surgery 
(Giannoni et al., 2002). Common dosing of Dexamethasone is 0.5 mg/kg IV. The benefit to using 
dexamethasone is that a single dose is considered safe. Risks involve long-term administration of 
corticosteroids that may be associated with adverse events, such as increased risk of infection,
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delayed wound healing, glucose intolerance, adrenal suppression, and vascular necrosis of the 
hip or other joints (Stoelting & Hillier, 2006).
Past studies conducted on dexamethasone’s analgesic potential in children have produced 
conflicting results; however, the most recent studies concur that dexamethasone contributes to 
analgesia when used in children undergoing tonsillectomy. Elhakim et al. (2003) produced a 
randomized, double-blind, placebo-controlled study using 120 participants to determine if a 
single dose of dexamethasone affected the severity of postoperative vomiting and pain in 
children undergoing electrocautery tonsillectomy under standardized general anesthesia. Results 
of the study revealed that the time to first oral intake was shorter and the time to first dose of 
analgesic was longer in the dexamethasone group (P < 0.01). Pain scores 30 min after extubation 
were lower (P < 0.05) in the dexamethasone group and at 12 and 24 hours postoperative 
swallowing was significantly less painful in the dexamethasone group than in the control group 
(P < 0.01). In a similar but smaller prospective, double-blinded, placebo-controlled study 
conducted by Kaan, Odabasi, Gezer, and Daldal (2006), 62 children (4-12 years of age) were 
randomly assigned to receive a single dose of 0.5 mg/kg iv dexamethasone preoperatively. 
Patients who received preoperative dexamethasone had a significantly less pain score during the 
first 6 hr postoperatively (P < 0.05), adequate oral intake time was shorter (P<0.05) and 
discharge time was earlier (P<0.05) than those treated with placebo. In those studies, 
preoperative dexamethasone was found to significantly reduce early post-tonsillectomy pain at 
rest and during swallowing, resulted in improved quality of oral intake during the first 24 hours, 
and facilitated meeting discharge criteria.
Dexamethasone has also proven effective when used to supplement other analgesics. 
Mohamed, Ibraheem, & Abdelraheem (2009) performed a double-blind randomized control trial
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on 150 children participants to determine the postoperative analgesic efficacy of the pre-surgical 
intravenous administration of dexamethasone in conjunction with glossopharyngeal nerve block 
(GNB) in children undergoing tonsillectomy. The study compared pre-operative dexamethasone 
IV injection with GNB to using either method alone. Absolute analgesia time was significantly 
longer in the group having both methods than either of the other two groups (P=0.000). Time to 
first request for analgesia was also significantly longer in the group that received both compared 
to the other groups (P=0.000). Patients in the group with both were discharged earlier from the 
hospital (P=0.000). Contradicting this study is one performed by Giannoni, White, & Enneking 
(2002). A prospective, randomized, double-blinded study was performed on 50 children 
comparing the effects of ropivicaine/clonidine injection with either dexamethasone (1 mg/kg up 
to 16 mg) or placebo saline (0.25 mL/kg up to 4 mL). Results indicated similar reported pain and 
narcotic use in the postanesthesia care unit and at home on all postoperative days measured. 
Overall, there was no decrease in pain and there was a trend to a longer recovery to normal 
activity in the group that received dexamethasone. Due to the small sample size of this study 
statistical effect may have been blunted.
Ketamine is a phencyclidine derivative that produces “dissociative anesthesia,” 
characterized by evidence on EEG of dissociation between the thalamocortical and the limbic 
system, which is responsible for interpretation of painful signals (Stoelting & Hillier, 2006). The 
state of unconsciousness produced is different from other anesthetics and the patient appears 
nonreactive to his/her environment. Ketamine binds noncompetitively to N-methyl-D-aspartate 
(NMDA) receptors located in the spinal cord dorsal horn (Stoelting & Hillier, 2006). Spinal cord 
sensitization is responsible for pain associated with touching or moving an injured body part, a 
process triggered by C fiber nociceptive input and activation of NMD A receptors (Stoelting &
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Hillier, 2006). Ketamine is hypothesized to provide preventative analgesia by preventing or 
reversing central sensitization and consequently reducing postoperative pain (Honarmand,
Safavi, & Jamshidi, 2008). The induction dose of ketamine is 1-2 mg/kg IV or 4-8 mg/kg IM. A 
subanesthetic dose of 0.2-0.5 mg/kg injected IM is proven to produce intense analgesia when 
injected through the tonsillar capsule.
Ketamine is water-soluble and has a rapid onset of action, relatively short duration of 
action, high lipid solubility, and is poorly bound to plasma proteins. Peak plasma concentrations 
of ketamine occur within 1 minute after IV administration and within 5 minutes after IM 
injection (Stoelting & Hillier, 2006). Benefits of using ketamine as an anesthetic include 
maintenance of blood pressure and preservation of laryngeal reflexes. It may be used for children 
presenting with neuromuscular disease associated with malignant hyperthermia triggered by 
volatile agents or neuromuscular blocking drugs. Ketamine is rarely associated with allergic 
reactions and does not evoke the release of histamine. Risks of using ketamine include 
psychodysphoric symptoms including visual, auditory, proprioceptive and confusional illusions, 
which may progress to delirium. Emergence delirium may limit the clinical usefulness of 
ketamine in children (Stoelting & Hillier, 2006).
Ketamine may be used intravascularly for analgesia; however, some of the most recent 
studies published have been on the use of ketamine for peritonsillar infiltration. Honarmand et al. 
(2008) conducted a randomized, double-blinded, placebo-controlled study to determine the effect 
of preincisional peritonsillar infiltration of two doses of ketamine and placebo of normal saline 
on postoperative pain relief in children undergoing adenotonsillectomy. Children’s Hospital 
Eastern Ontario Pain Scale (CHEOPS) scores were significantly higher in the placebo group 
compared to the other two groups (P < 0.001). Results indicated that peritonsillar infiltration
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with 0.5 or 1 mg/kg dose of ketamine given approximately 3 min before surgery provides 
efficient pain relief for the first 24 hours after surgery without side-effects in children undergoing 
adenotonsillectomy. Time to extubation was significantly longer in the ketamine groups than the 
saline group. Although the study seemed to be well thought out, further research on the 
difference between a ketamine injection and that of a local anesthetic (opposed to saline) would 
be intriguing. Erhan, Goksu, Alpay, & Bestas (2007) conducted a similar study to determine the 
effectiveness of ketamine 0.5 mg/kg by peritonsillar infiltration. Results indicated the CHEOPS 
value, the time to first anesthetic, and the total amount of analgesic were all in favor of ketamine 
use (p<0.05).
An interesting randomized, controlled and double-blinded study on IV use of ketamine 
was conducted by Inanoglu, Ozbakis, Turhanoglu, Okuyucu, & Akoglu (2009) to determine the 
analgesic effects of IV ketamine with peritonsillar infiltration of bupivacaine on children 
undergoing tonsillectomy. The study involved three groups. Group I received intravenous and 
peritonsillar saline, Group II received intravenous saline and peritonsillar bupivacaine, and group 
III received intravenous 0.5 mg/kg ketamine and peritonsillar 0.25% bupivacaine 3-5 ml per 
tonsil. CHEOPS scores were used to evaluate pain and it was recorded at 6 different time 
intervals. Analgesic requirements were significantly (P<0.05) less and time to first analgesia 
were significantly (P<0.05) longer in the ketamine group.
Eishammaa et al. (2011) conducted a double blinded, randomized trial of 60 children 
between the ages 2 and 7 to determine if ketamine, as an adjunct to fentanyl, improved 
postoperative pain control in children undergoing tonsillectomy. Children were divided into four 
groups including, fentanyl 1 mcg/kg group, fentanyl 2 mcg/kg group, ketamine 0.5 mg/kg group, 
and fentanyl 1 mcg/kg plus ketamine 0.5 mg/kg group. Results of this study indicated that the
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administration of ketamine 0.5 mg/kg with 1 mcg/kg fentanyl may improve postoperative pain 
control without delaying home discharge; however, this data may be skewed by the small 
number of subjects in each individual group.
In the studies discussed it would appear ketamine may serve as a useful adjunct to 
treatment of post-tonsillectomy pain. Many researchers have not reproduced similar results.
Batra et al. (2007) conducted a randomized, double-blind, placebo-controlled prospective study 
of 40 children and found that use of small-dose ketamine, in conjunction with remifentanil, did 
not have a significant morphine-sparing effect in the perioperative period and did not 
significantly decrease postoperative pain in children after tonsillectomy. Another randomized 
double-blind study that did not find a significant decrease in postoperative morphine 
consumption post-tonsillectomy was conducted by Abu-Shahwan in 2008. This study included 
84 subjects and compared two groups, one that received morphine and another that received 
morphine and 0.25 mg/kg ketamine at induction. A lack of significant results in these studies 
may be due to the small number of subjects. Those studies that found ketamine contributing to 
decreased opioid use were often using the higher 0.5 mg/kg ketamine dose in their research.
Dexmedetomidine is a highly selective, specific, and potent alpha2-adrenergic agonist 
with anxiolytic, sedative, and analgesic properties (Stoelting & Hillier, 2006). The primary 
analgesic effect is mediated via action of the alpha2 receptors on the dorsal horn of the spinal 
cord and also by inhibition of substance P (Tobias, 2007). Pretreatment with dexmedetomidine 
attenuates hemodynamic responses to tracheal intubation, decreases plasma catecholamine 
concentrations during anesthesia, decreases perioperative requirements for inhaled anesthetics 
and opioids, and increases likelihood of hypotension (Stoelting & Hillier, 2006). It has analgesic 
and sedative properties with minimal impact on respiratory function and decreases analgesic
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requirements after surgery. High doses (loading dose of 1 mcg/kg IV followed by 0.25-0.5 
mcg/kg/hour IV) produces total IV anesthesia without associated depression of ventilation 
(Tobias, 2007). The elimination half-time is 2-3 hours, it is highly protein bound (>90%), 
undergoes extensive hepatic metabolism and is excreted by the kidneys (Stoelting & Hillier, 
2006). It has an inhibiting effect on cytochrome P450 enzyme system which manifests as 
increased plasma concentrations of opioids (Tobias, 2007).
Advantages of using dexmedetomidine are the mild analgesic properties, the ability to 
cause sedation without respiratory depression, and the fact that it does not have an effect on 
coagulation (Olutoye et al., 2010). Disadvantages include the sympatholytic effects and 
vagomimetic actions that result in decreased arterial blood pressure and heart rate which may be 
of concern in anesthetized children with a rate dependent cardiac output (Stoelting & Hillier, 
2006). It also has a tendency to increase the range of temperatures likely to trigger 
thermoregulatory defenses, which may promote perioperative hypothermia.
Dexmedetomidine has been gaining popularity for use as an anesthetic in adults and 
studies are now being conducted to determine its relevance in pediatric anesthesia. Olutoye et al. 
(2010) conducted a prospective, randomized, double-blind study on 109 pediatric patients. The 
patients were put into one of four groups and received either a single IV dose of 
dexmedetomidine (0.75 mcg/kg), dexmedetomidine (1 mcg/kg), morphine (50 mcg/kg) or 
morphine (100 mcg/kg). Median time to first postoperative rescue analgesic was significantly 
longer in the dexmedetomidine 1 mcg/kg and morphine 100 mcg/kg compared to the other two 
groups (P < 0.01). Those participants who received dexmedetomidine compared to those who 
received morphine had significantly slower postoperative heart rate. The number of children who 
required >1 dose of rescue analgesic was significantly higher in the dexmedetomidine 0.75
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mcg/kg group compared with dexmedetomidine 1.0 mcg/kg and morphine 100 mcg/kg groups 
(P=0.03 and P=0.013). Another study conducted by Patel, et al. (2010) used a prospective, 
randomized, blinded, controlled approach to research 137 children. They were assigned to either 
a dexmedetomidine infusion group (2 mcg/kg over 10 minutes, followed by 0.7 mcg/kg/h until 5 
minutes before the end of surgery) or IV fentanyl group (1 mcg/kg) to determine its effect on 
perioperative opioid use. The amount of participants who needed rescue fentanyl for pain was 
significantly lower in the dexmedetomidine group compared to fentanyl (P == 0.001). Mean heart 
rate and mean systolic blood pressure were significantly lower in group dexmedetomidine during 
the first 60 minutes (P = 0.019). In this study, those who received the dexmedetomidine bolus 
and infusion had decreased intraoperative opiate and anesthetic requirements and decreased 
opiate requirements in the PACU compared to the IV fentanyl group.
A separate double-blind, randomized trial was conducted by Pestieau et al. (2011) to 
determine whether high doses of dexmedetomidine had an impact on opioid requirements and 
the opioid-free interval after tonsillectomy. 109 patients were assigned to one of four treatment 
groups. Group one was given fentanyl 1 mcg/kg, group two was given fentanyl 2 mcg/kg 
(current standard of practice groups), group 3 was given dexmedetomidine 2 mcg/kg and group 4 
was given dexmedetomidine 4 mcg/kg. Results showed that dexmedetomidine prolongs the 
opioid-free interval after tonsillectomy and appears to decrease overall morphine requirements as 
well as the risk of morphine-rescue administration. The dexmedetomidine groups did have a 
prolonged time to emergence from anesthesia and an increased length of stay in the PACU. 
Dexmedetomidine appears to have opioid-sparing effects and was recommended by the authors 
to be considered as an adjunct for analgesia during and after tonsillectomies.
Use of dexmedetomidine in young, healthy patients may be restricted by its association
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with episodes of bradycardia and sinus arrest. Cardiac output in pediatric patients is heart rate 
dependent, requiring maintenance of a regular rate and rhythm. Hypertension has also been 
observed following an initial bolus dose of dexmedetomidine. As with any pharmacologic agent, 
caution must be used when administering to a patient.
Local anesthetics have proven to be effective as an adjunct in the relief of postoperative 
pain. Many studies have shown bupivacaine to be more effective than levobupivicaine and 
ropivacaine when injected by the surgeon into the peritonsillar area at the completion of surgery. 
A randomized clinical trial comparing rectal acetaminophen with peritonsillar infiltration of 
bupivacaine for postoperative analgesia after adenotonsillectomy in children was conducted by 
Dahi-Taleghani, Mousavifard, Tahmoureszade, & Dabbagh (2011). The trial included 110 
participants who were randomly separated into two groups, one receiving 30 mg/kg rectal 
acetaminophen and one receiving 1 mg/kg bupivacaine injection after intubation and prior to 
tonsillectomy. Results indicated that there was no difference between the two groups regarding 
throat pain at rest, after swallowing, after taking fluid and after soft food intake. The minimal 
amount of risk associated with rectal acetaminophen administration made it superior to 
bupivacaine injection in their opinion.
Opioid Medications
Opioids provide analgesia by binding to specific receptors located primarily in the brain 
and spinal cord. They inhibit the release of substance P blocking pain pathways ascending to the 
brain where pain is perceived (Stoelting & Hillier, 2006). They also activate descending 
pathways to inhibit the transmission of nociceptive information (Golembiewski, Torrecer, & 
Katke, 2005). Opioids are frequently used for postoperative treatment of moderate to severe pain, 
Adverse effects of opioids include: respiratory depression, sedation, nausea and vomiting,
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pruritus, constipation and voiding difficulties. Depression of ventilation occurs primarily through 
an agonist effect at mu2 receptors leading to a direct depressant effect on brainstem ventilation 
centers (Stoelting & Hillier, 2006). Opioid action on kappa receptors leads to sedation which 
may prolong post-operative recovery. Nausea and vomiting associated with opioids is due to 
direct stimulation of the chemoreceptor trigger zone in the floor of the fourth ventricle (Stoelting 
& Hillier, 2006). The proportional increase in side effects with opioid use may lead to 
administration of smaller doses of the medication and decreased analgesia for patients.
Morphine is the prototype opioid and the agent to which all other opioids are compared.
It has low lipid solubility and peak effect occurs 15-20 minutes after IV injection (Stoelting & 
Hillier, 2006). Morphine undergoes an extensive first-pass effect and is metabolized hepatically 
to morphine-3-gluronide (M-3-G) and morphine-6-glurcorunide (M-6-G) (Golembiewski et al, 
2005). M-6-G provides greater analgesia than morphine and M-3-G provides no analgesia. Both 
byproducts are renally excreted (Golembiewski, 2005). The pediatric dose is 0.05-0.2 
mg/kg/dose up to 15 mg and it provides several hours of analgesia. Disadvantages of using 
morphine include histamine release, pruritis, and hypotension. It must be used with caution in 
patients with hepatic impairment because it is metabolized by the liver. The active metabolites 
could accumulate and cause excessive sedation and respiratory depression. Caution should be 
used when administering to patients with renal impairment as well. According to Brown, 
Laferriere, Lakheeram, & Moss (2006), postsurgical administration of opiates in patients with 
obstructive sleep apnea (OSA) has recently been linked to an increased risk for respiratory 
complications. Previous recurrent hypoxemia in OSA has also been associated with increased 
analgesic sensitivity to subsequent morphine administration (Brown et al., 2006). Tonsillectomy 
and adenoidectomy is often performed on children with enlarged (hypertrophic) tonsils that
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cause obstruction (often manifested by snoring) when the children are lying supine. The 
significance of these findings is due to the relationship between OSA and patients undergoing 
surgery for T&A.
Fentanyl is a phenylpiperidine-derivative synthetic opioid agonist. It is 75-125 times 
more potent than morphine due to greater lipid solubility (Stoelting & Hillier, 2006). It is more 
rapid in onset and shorter in duration of action than morphine and hydromorphone. Fentanyl has 
a larger volume of distribution and longer elimination half-time than morphine (Golembiewski et 
al., 2005). A common dose in pediatric patients is 1-2 mcg/kg IV. Fentanyl does not produce 
histamine release as morphine does. Risks of using fentanyl include persistent or recurrent 
depression of ventilation, bradycardia, hypotension, decreased cardiac output and chest rigidity 
with high doses. The analgesic effects of fentanyl last for up to one hour. Available literature 
suggests that differences in metabolism require modification in dosing and that 2-6 year old 
children have a more rapid metabolism, meaning that such children may require more frequent 
dosing. Fentanyl is used as the primary intraoperative analgesic in the majority of the literature 
reviewed. Recent studies have been directed at finding an alternative to fentanyl as an analgesic 
due to the respiratory depressant effects it possesses.
Remifentanil is a selective mu opioid agonist, structurally unique due to its ester linkage 
which renders it susceptible to hydrolysis by nonspecific plasma and tissue esterases to inactive 
metabolites. This form of metabolism imparts brevity of action, precise and rapidly titratable 
effect due to its rapid onset and offset, noncumulative effects, and rapid recovery after 
discontinuation of its administration. It has an analgesic potency similar to fentanyl and effect- 
site (blood/brain) equilibration time much faster than that of fentanyl (1.1 min vs. 6.8). It has a 
small volume of distribution, is rapidly cleared and renally excreted. Beneficial effects of
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remifentanil include rapid onset of drug effect, precise titration to the desired effect, ability to 
maintain a sufficient plasma opioid concentration to suppress the stress response, and rapid 
recovery from the drug’s effects. With remifentanil there is a predictability of drug effect due to 
esterase metabolism. Lack of accumulation during extended periods of infusion prevents 
prolonged clearance not seen with sufentanil or fentanyl. There is no histamine release with 
remifentanil. The common recommended dose is 1 mcg/kg IV over 60-90 seconds. The 
combination of remifentanil and propofol is synergistic resulting in severe depression of 
ventilation. A longer-acting opioid must be administered for post-operative analgesia when 
remifentanil is used. Associated side effects include nausea and vomiting, depression of 
ventilation and mild decreases in systemic blood pressure and heart rate.
Davis et al. (2000) conducted a double-blinded study to determine the effectiveness of 
remifentanil versus fentanyl in pediatric tonsillectomy patients. The two groups were randomly 
selected to receive either remifentanil bolus with continuous infusion 0.25 microg/kg/min or a 
fentanyl bolus of 2 mcg/kg followed by a placebo continuous infusion. Remifentanil provided 
faster extubation times, although those patients had higher pain-discomfort scores. The 
researchers concluded that remifentanil was as effective intraoperatively as fentanyl, however 
better intraoperative prophylactic analgesic regimens for postoperative pain control were 
necessary to optimize remifentanil’s use as an analgesic for children. More research is being 
conducted on remifentanil in association with painful procedures in neonates such as 
endotracheal intubation and mechanical ventilation and central line placement.
Sufentanil is a thienyl analogue of fentanyl. The analgesic potency is 5-10 times that of 
fentanyl with greater affinity to opioid receptors. It is highly lipid soluble, has extensive protein 
binding, and has a smaller volume of distribution than fentanyl. Elimination half-time is between
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that of fentanyl and alfentanil. A common dose is 0.1-0.4 mcg/kg. Sufentanil use is beneficial 
over fentanyl due to production of longer periods of analgesia and less depression of ventilation. 
It should be used with caution in patients with chronic renal failure and chest wall rigidity may 
occur with high doses. The only study found on the use of sufentanil in tonsillectomy was 
conducted by Bayrak, Gunday, Memis, & Turan (2007). Results indicated that an intranasal 
sufentanil dose of 2 micrograms/kg provided anxiety and cooperation scores similar to that of 
oral midazolam when used perioperatively.
Hydromorphone is a hydrophilic opioid and a semi-synthetic derivative of morphine. It is 
5-10 times more potent, has a longer serum half-life (3 vs 2 hr), and volume of distribution (4.5 
vs 3 L/kg) than morphine. It produces more sedation and evokes less euphoria than morphine. 
Hydromorphone has a lipid solubility range that falls between morphine and fentanyl.
Breakdown products include hydromorphone-6-glucuronide and hydromorphone-3-gluronide 
which have no analgesic properties and are renally excreted. H-3-G may have potential to cause 
neuroexcitatory effects when high levels occur in a patient with renal failure with chronic dosing. 
The recommended pediatric dose is 1 mcg/kg. Journal articles recently published describe 
medication errors related to hydromorphone overdose. Many patients are experiencing acute 
respiratory depression, sedation, severe hypotension and in multiple cases cardiopulmonary 
arrest and death. While the drug when used appropriately seems to be effective, errors occur due 
to misunderstanding about the drugs equi-analgesic dosing when compared with morphine. 
McDonnell (2011) looked at opioid medication errors in pediatric practice and found that 
medication errors involving hydromorphone and codeine resulted in the most significant harm 
reported. Pharmacological advantages that hydromorphone offers over morphine include a 
longer half-life and lack of metabolites. Unfortunately, literature on hydromorphone use in
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pediatric patients is rare and studies conducted to support hydromorphone for clinical use is 
nonexistent.
Discussion
Each painful experience a patient has accumulated through their lifetime plays a role in 
how the patient will respond to the existing painful experience. Family background, emotional 
status, expectations, and physiological variables all affect a patient’s perception of and 
experience with pain. A large component present in children is the emotional part of the pain 
experience. They are affected by factors such as the presence or absence of caregivers and fears 
related to unfamiliar surroundings, people and procedures. Each person will respond differently 
to the same painful procedure, so how do we know that someone is, in fact, having pain.
Pain can be assessed in a variety of ways, including self-report, behavioral observation or 
physiologic measures. Verbal self-report of pain is considered the gold standard for assessment. 
In patients undergoing general anesthesia verbal self-report is not an option. Pain is assessed by 
CRNAs throughout the intraoperative period through physiologic measures. Blood pressure, 
heart rate, and respiratory rate are among the most commonly used physiologic means to monitor 
pain. Inability to communicate does not imply that pain does not exist, but children who can’t 
verbalize are an example of the importance of an accurate and sensitive assessment of pain.
Pain scales have been developed to help assess and guide the administration of 
analgesics; however, they lack precision and reliability to exclusively direct analgesic dosing. 
While assessment tools have become a standard measure in which to monitor a child’s pain, 
choosing the appropriate assessment tool for the patient’s age, developmental stage and context 
of the pain experience is difficult and creates variability among providers. Refining or modifying
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pain scales may be needed to make pain assessment more reliable and consistent.
Once the appropriate pain scale has been chosen, the patient has been assessed as having 
significant pain, and the decision to proceed with administration of an analgesic has been made, 
healthcare providers continue to experience barriers to treating pain. The primary concern in 
providers administering opioid analgesics is the fear of causing respiratory depression in the 
child. Other barriers that have been researched include fear of addiction and an overall lack of 
knowledge on pediatric pain treatment.
Inadequate treatment of pain leads to adverse physiological effects which may delay 
healing and contribute to increased healthcare costs. Increased respiratory rate and decreased 
volume can lead to retained secretions and atelectasis. Heart rate, cardiac output, and systemic 
vascular resistance may be increased with pain and lead to increased blood pressure and 
myocardial 02 consumption. Pain increases the release of stress hormone and also increases the 
metabolic rate. It depresses the immune system predisposing patients to infection.
Effective control of postoperative pain involves several preventative strategies that 
include preoperative analgesia, appropriate use of intraoperative analgesic techniques, and 
identification of children at risk for significant postoperative pain. There are several 
complimentary and integrative medicine approaches that may be used in addition to 
pharmacologic methods of analgesia. Acupuncture and acupressure, therapeutic touch, yoga, 
massage, heat and cold therapy, naturopathy, and physical therapy/occupational therapy have all 
been studied in relation to attenuating postoperative pain. Cognitive and behavioral approaches 
including: patient/family education, psychotherapy, relaxation and imagery, therapeutic play, 
music therapy, and animal therapy have been researched as well.
Pharmacologic agents chosen to treat pain vary from practitioner to practitioner. As more
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research is conducted on the pharmacokinetic and pharmacodynamic propert ies of these agents, 
more knowledge is being revealed on mechanism and sites of action of these analgesic drugs. 
Although these analgesic drugs continue to be investigated, ethical considerations in the study of 
pediatric populations often hinders researchers from performing randomized controlled trials that 
direct pain management in children.
Multimodal analgesia is the concept of using different classes of analgesics for pain 
alteration at various receptor sites to provide the maximum analgesic effect with reduced 
analgesic-related side effects (Joshi, 2005). Many clinicians are utilizing the multimodal 
approach to pain management in an attempt to reduce the unwanted side effects of giving large 
doses of a particular drug. For instance, acetaminophen and NSAIDs when given in conjunction 
with opioids may reduce the amount of opioid required. This may lead to decreased risk of side 
effects in opioids such as respiratory depression and nausea/vomiting. It is also important to note 
the synergistic effects of analgesics, anxiolytics, antiemetics, and antihistamines require ongoing 
assessment of sedation and analgesia.
Treating pain early and effectively is safer, more efficacious and results in improved 
patient comfort. It may also result in less total analgesic administered.
Outcome
This information was presented to CRNAs and current nurse anesthesia students at the 
Fall 2011 meeting of the North Dakota Association of Nurse Anesthetists in Bismarck, ND. 
Included in the power point presentation were an introduction, statement of problem, purpose of 
the study, significance of the study, areas of inquiry, overview of methods, and references.
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Implications for Nursing
Dosing analgesics for the management of postoperative pain in children continues to 
challenge anesthesia providers and the nurses recovering them. Finding the specific combination 
of medications that provides the most effective relief of postoperative pain in children may be an 
idealistic goal. It is critical that anesthesia providers and recovery nurses realize that children, 
like adults, do not all respond to pain the same way.
There is a continued need for research in the area of intraoperative pain management, 
especially in the pediatric population. Of those analgesics that have been studied, many have 
conflicting results which contributes to confusion. It was disappointing to learn that there was 
limited or no information on children regarding some analgesics commonly used in adults. 
Providers need to stay current on the most recent studies and their findings on pediatric pain 
management and challenge themselves to provide a multimodal analgesic that result in effective 
postoperative pain control. Anesthetic practice may need to be altered as new information and 
techniques for intraoperative pain management emerge. Hospital policies need to incorporate 
standards for the assessment and treatment of postoperative pediatric pain in the postanesthesia 
care unit. It is important that patients and their parents are satisfied with their perioperative 
experience.
Conclusion
Postoperative pediatric pain remains a significant morbidity associated with surgery in 
children. Many analgesic medications with a variety of dosages and means of administration 
were identified in the literature. Although the research does not seem to highlight one 
intraoperative analgesic technique proven to be the most effective, many combinations of
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medications may be used to provide analgesia. There is a continued need for research on 
postoperative pediatric pain and on analgesic agents that have not yet been studied in children. 
Pain management should be one of the primary goals of healthcare providers managing pediatric 
patients undergoing surgical procedures.
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